Moneta Money Bank AS (0RGC)
London Exchange · UK · prices in GBP · close of 23 Oct 2026
Key indicators
| Last close | GBP 82.45 |
|---|---|
| 52-week range | 82.45 – 200.00 |
| Return, 1 month / 3 months | +0.0% / +0.0% |
| Return, 1 year / 3 years | +0.2% / +0.5% |
| Trend | Below its 200-day average |
| RSI (14) | 47 |
| Volatility (1 year) | 199.7% |
| Worst drawdown (1 year) | -57.5% |
| Average daily value traded | 0.06M GBP |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Moneta Money Bank is a Czech bank based in Prague that serves individuals, small businesses and larger corporate clients. It offers current and savings accounts, mortgages, consumer loans, credit cards and insurance products to retail customers, and provides business accounts, lending and payment services to companies. The bank also offers investment and card services, and it operates largely through a branch network supported by digital banking channels across the Czech Republic.
On this site Moneta Money Bank AS appears as a stock on the London Exchange (UK), code 0RGC, with prices in pounds sterling (GBP). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Moneta Money Bank AS (0RGC) trades on the London Exchange in UK. It last closed at GBP 82.45 on 23 October 2026.
Its price-based Market X-Ray is 27 out of 100 (a weak price profile), ranking 3,181 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 0.2% and over the last three months it rose 0.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 30 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -2.4% | ||
| From 52-week high | -57.5% | ||
| Momentum | 50 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 0.0% | ||
| 6-month return | 0.1% | ||
| 12-month return, skipping the last month | 0.2% | ||
| Stability (higher is calmer) | 7 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 199.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -57.5% | ||
| Liquidity | 18 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.06M GBP | ||
| Zero-volume days | 95.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 6 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | +0.0% |
| 3 months | +0.0% |
| 6 months | +0.1% |
| 1 year | +0.2% |
| 3 years | +0.5% |
| 5 years | +0.7% |
Signals
| 50-day / 200-day average | 82.45 / 84.51 |
|---|---|
| Golden / death cross (60 days) | Death, 47 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 45.21 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 24 Apr 2026 | GBX 0.1150 |
| 20 Nov 2025 | GBX 0.0400 |
| 29 Apr 2025 | GBX 0.1000 |
| 22 Nov 2024 | GBX 0.0300 |
| 26 Apr 2024 | GBX 0.0900 |
| 28 Apr 2023 | GBX 0.0800 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.